pdei1 ppi2
Name
pdei2
Label
Phosphodiesterase Inhibitors (SHHS2)
Description

Participant taking PHOSPHODIESTERASE INHIBITORS within two weeks of the SHHS2 visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Domain
noyes01
  • 0: No
  • 1: Yes
Type
choices
Tags
PDEI2
Phosphodiesterase Inhibitors (SHHS2) vs SHHS Visit Number
Visit 1 Visit 2 CVD Outcomes
Total 5,804 4,080 5,042
No - 3,555 -
Yes - 65 -
Unknown 5,804 460 5,042
Phosphodiesterase Inhibitors (SHHS2) vs Age at SHHS1
Visit 1
39.0 to 55.0 years 55.0 to 63.0 years 63.0 to 72.0 years 72.0 to 100.0 years Total
Total 1,451 1,451 1,451 1,451 5,804
No - - - - -
Yes - - - - -
Unknown 1,451 1,451 1,451 1,451 5,804
Phosphodiesterase Inhibitors (SHHS2) vs Gender
Visit 1
Female Male Total
Total 3,039 2,765 5,804
No - - -
Yes - - -
Unknown 3,039 2,765 5,804
Phosphodiesterase Inhibitors (SHHS2) vs Gender
Visit 2
Female Male Total
Total 2,219 1,861 4,080
No 1,920 1,635 3,555
Yes 39 26 65
Unknown 260 200 460
Phosphodiesterase Inhibitors (SHHS2) vs Race
Visit 1
white black native amer/alaskan asian/pacific islander hispanic/mex. amer other Total
Total 4,907 515 11 88 280 3 5,804
No - - - - - - -
Yes - - - - - - -
Unknown 4,907 515 11 88 280 3 5,804
Phosphodiesterase Inhibitors (SHHS2) vs Race
Visit 2
white black native amer/alaskan asian/pacific islander hispanic/mex. amer other Total
Total 3,587 256 8 48 180 1 4,080
No 3,107 232 6 43 166 1 3,555
Yes 55 10 - - - - 65
Unknown 425 14 2 5 14 - 460